Deciphera Pharmaceuticals, Inc. Quarterly Operating Income (Loss) in USD from Q1 2016 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Deciphera Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2016 to Q1 2024.
  • Deciphera Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$48.8M, a 8.28% increase year-over-year.
  • Deciphera Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$207M, a 9.23% decline year-over-year.
  • Deciphera Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$211M, a 15.5% decline from 2022.
  • Deciphera Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$183M, a 39.1% increase from 2021.
  • Deciphera Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$300M, a 10.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$207M -$48.8M +$4.41M +8.28% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 -$211M -$51.2M -$4.08M -8.65% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-07
Q3 2023 -$207M -$53.7M -$8.81M -19.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-10-30
Q2 2023 -$198M -$52.8M -$8.99M -20.5% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 -$189M -$53.3M -$6.37M -13.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$183M -$47.2M +$41.2M +46.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-07
Q3 2022 -$224M -$44.9M +$34.8M +43.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-30
Q2 2022 -$259M -$43.8M +$26.7M +37.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$285M -$46.9M +$14.6M +23.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 -$300M -$88.4M -$25.4M -40.3% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-07
Q3 2021 -$275M -$79.7M -$15.7M -24.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$259M -$70.5M -$1.58M -2.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$257M -$61.5M +$13.8M +18.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 -$271M -$63M +$7.37M +10.5% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-09
Q3 2020 -$279M -$64M -$5.64M -9.67% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 -$273M -$68.9M -$46M -200% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 -$227M -$75.3M -$26.2M -53.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 -$201M -$70.4M -$36.5M -108% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-09
Q3 2019 -$164M -$58.4M -$32.5M -125% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-09
Q2 2019 -$132M -$23M -$546K -2.43% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-09
Q1 2019 -$131M -$49M -$27.1M -123% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-09
Q4 2018 -$104M -$33.8M -$13.5M -66.3% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-09
Q3 2018 -$90.6M -$25.9M -$13.7M -113% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-09
Q2 2018 -$76.9M -$22.4M -$11.7M -110% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-09
Q1 2018 -$65.2M -$22M -$14.2M -184% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-09
Q4 2017 -$50.9M -$20.3M -$11.8M -138% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-14
Q3 2017 -$39.1M -$12.2M -$6.11M -101% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-14
Q2 2017 -$33M -$10.7M -$4.78M -80.8% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-14
Q1 2017 -$28.2M -$7.73M -$2.4M -45.1% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-14
Q4 2016 -$25.8M -$8.53M Oct 1, 2016 Dec 31, 2016 10-K 2018-03-28
Q3 2016 -$6.07M Jul 1, 2016 Sep 30, 2016 10-K 2018-03-28
Q2 2016 -$5.91M Apr 1, 2016 Jun 30, 2016 10-K 2018-03-28
Q1 2016 -$5.32M Jan 1, 2016 Mar 31, 2016 10-K 2018-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.